<--- Back to Details
First PageDocument Content
Subclavian vein / Axillary artery / Peripheral venous catheter / Port / Internal jugular vein / Axillary vein / Basilic vein / Intravenous therapy / External jugular vein / Medicine / Catheters / Central venous catheter
Date: 2014-07-23 07:16:24
Subclavian vein
Axillary artery
Peripheral venous catheter
Port
Internal jugular vein
Axillary vein
Basilic vein
Intravenous therapy
External jugular vein
Medicine
Catheters
Central venous catheter

A new percutaneous infraclavicular approach to the axillary vein RWD Nickalls 1 Anaesthesia (1987); vol. 42, pp. 151–154 http://www.nickalls.org/dick/papers/anes/axillaryvein1987.pdf

Add to Reading List

Source URL: www.nickalls.org

Download Document from Source Website

File Size: 1,61 MB

Share Document on Facebook

Similar Documents

California Naturopathic Medicine Committee - Intravenous Therapy Approved Providers

California Naturopathic Medicine Committee - Intravenous Therapy Approved Providers

DocID: 1tWfs - View Document

FOR IMMEDIATE RELEASE  FDA Approves Carnexiv™ (carbamazepine) injection as Intravenous Short-Term Replacement Therapy for Certain Seizure Types Carnexiv is the first FDA-approved intravenous carbamazepine option Health

FOR IMMEDIATE RELEASE FDA Approves Carnexiv™ (carbamazepine) injection as Intravenous Short-Term Replacement Therapy for Certain Seizure Types Carnexiv is the first FDA-approved intravenous carbamazepine option Health

DocID: 1taCQ - View Document

Intravenous	
  infusion	
  practice	
  as	
  a	
   complex	
  cognitive	
  system:	
  Exploring	
   layers	
  of	
  Distributed	
  Cognition	
   Dominic	
  Furniss 1 ,	
  Imogen	
  Lyons 1 ,	
  Bryony

Intravenous  infusion  practice  as  a   complex  cognitive  system:  Exploring   layers  of  Distributed  Cognition   Dominic  Furniss 1 ,  Imogen  Lyons 1 ,  Bryony

DocID: 1rhqf - View Document

Package leaflet: Information for the user Elaprase 2 mg/ml concentrate for solution for infusion Idursulfase ▼This medicine is subject to additional monitoring. This will allow quick identification of new safety inform

Package leaflet: Information for the user Elaprase 2 mg/ml concentrate for solution for infusion Idursulfase ▼This medicine is subject to additional monitoring. This will allow quick identification of new safety inform

DocID: 1reFq - View Document

Fresenius Kabi USA, LLC Three Corporate Drive Lake Zurich, IllinoisTTwww.fresenius-kabi.us

Fresenius Kabi USA, LLC Three Corporate Drive Lake Zurich, IllinoisTTwww.fresenius-kabi.us

DocID: 1r4t7 - View Document